PDCD1 and aggressive NK-cell leukemia: In this study, we retrospectively analyzed the clinical characteristics and treatment regimens of ANKL patients in our single center to explore the prognosis of ANKL patients in a real-world setting and the impact of PD-1 antibodies on prognosis.